Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
Apply
Pembrolizumab & GVD
Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step